Core Viewpoint - The stock of Kefu Medical (301087) has shown a decline in price and mixed capital flow trends, with institutional ratings remaining positive despite recent fluctuations in trading volume and price [1][2][4]. Group 1: Stock Performance - As of November 11, 2025, Kefu Medical's stock closed at 44.5 yuan, down 1.09% with a turnover rate of 0.78% and a trading volume of 15,200 lots, resulting in a transaction amount of 67.95 million yuan [1]. - Over the past five days, the stock has experienced a price decline, with a notable drop of 1.09% on November 11, following a decrease of 1.08% on November 10 [2]. Group 2: Capital Flow Analysis - On November 11, 2025, the net outflow of main funds was 312.12 thousand yuan, accounting for 4.59% of the total transaction amount, while retail investors saw a net inflow of 296.41 thousand yuan, representing 4.36% of the total [1][2]. - The capital flow data indicates a shift in investor sentiment, with retail investors showing a preference for buying despite the overall decline in stock price [2]. Group 3: Financial Metrics and Industry Comparison - Kefu Medical's total market capitalization is 9.296 billion yuan, with a net asset value of 4.75 billion yuan and a net profit of 260 million yuan, ranking 42nd, 29th, and 24th respectively in the medical device industry [3]. - The company reported a gross margin of 53.35% and a net margin of 10.82%, both of which are above the industry averages, indicating strong operational efficiency [3]. - For the first three quarters of 2025, Kefu Medical's main revenue reached 2.398 billion yuan, a year-on-year increase of 6.63%, while the net profit rose by 3.3% to 260 million yuan [3]. Group 4: Institutional Ratings - In the last 90 days, eight institutions have rated Kefu Medical with a "buy" recommendation, and the average target price set by these institutions is 53.84 yuan [4].
股票行情快报：可孚医疗（301087）11月11日主力资金净卖出312.12万元